Shreeram Agharkar - Net Worth and Insider Trading
Shreeram Agharkar Net Worth
The estimated net worth of Shreeram Agharkar is at least $4,422 dollars as of 2024-11-13. Shreeram Agharkar is the Director of Relmada Therapeutics Inc and owns about 1,340 shares of Relmada Therapeutics Inc (RLMD) stock worth over $4,422. Details can be seen in Shreeram Agharkar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shreeram Agharkar has not made any transactions after 2015-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shreeram Agharkar
Shreeram Agharkar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shreeram Agharkar owns 1 companies in total, including Relmada Therapeutics Inc (RLMD) .
Click here to see the complete history of Shreeram Agharkar’s form 4 insider trades.
Insider Ownership Summary of Shreeram Agharkar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2015-12-16 | director |
Shreeram Agharkar Latest Holdings Summary
Shreeram Agharkar currently owns a total of 1 stock. Shreeram Agharkar owns 1,340 shares of Relmada Therapeutics Inc (RLMD) as of December 16, 2015, with a value of $4,422.
Latest Holdings of Shreeram Agharkar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2015-12-16 | 1,340 | 3.30 | 4,422 |
Holding Weightings of Shreeram Agharkar
Shreeram Agharkar Form 4 Trading Tracker
According to the SEC Form 4 filings, Shreeram Agharkar has made a total of 0 transactions in Relmada Therapeutics Inc (RLMD) over the past 5 years. The most-recent trade in Relmada Therapeutics Inc is the acquisition of 275 shares on December 16, 2015, which cost Shreeram Agharkar around $3,773.
Insider Trading History of Shreeram Agharkar
- 1
Shreeram Agharkar Trading Performance
GuruFocus tracks the stock performance after each of Shreeram Agharkar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Shreeram Agharkar is -62.16%. GuruFocus also compares Shreeram Agharkar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Shreeram Agharkar within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Shreeram Agharkar's insider trading performs compared to the benchmark.
Performance of Shreeram Agharkar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -45.95 | | | | | |
| Relative Return to S&P 500(%) | -36.65 | | | | | |
Shreeram Agharkar Ownership Network
Ownership Network List of Shreeram Agharkar
Ownership Network Relation of Shreeram Agharkar
Shreeram Agharkar Owned Company Details
What does Relmada Therapeutics Inc do?
Who are the key executives at Relmada Therapeutics Inc?
Shreeram Agharkar is the director of Relmada Therapeutics Inc. Other key executives at Relmada Therapeutics Inc include director & Chief Executive Officer Sergio Traversa , Chief Financial Officer Chuck Ence , and Chief Medical Officer Cedric O'gorman .
Relmada Therapeutics Inc (RLMD) Insider Trades Summary
Over the past 18 months, Shreeram Agharkar made no insider transaction in Relmada Therapeutics Inc (RLMD). Other recent insider transactions involving Relmada Therapeutics Inc (RLMD) include a net purchase of 240,000 shares made by Sergio Traversa , a net purchase of 86,107 shares made by Maged Shenouda , and a net purchase of 38,970 shares made by Chuck Ence .
In summary, during the past 3 months, insiders sold 0 shares of Relmada Therapeutics Inc (RLMD) in total and bought 231,432 shares, with a net purchase of 231,432 shares. During the past 18 months, 0 shares of Relmada Therapeutics Inc (RLMD) were sold and 413,077 shares were bought by its insiders, resulting in a net purchase of 413,077 shares.
Relmada Therapeutics Inc (RLMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relmada Therapeutics Inc Insider Transactions
Shreeram Agharkar Mailing Address
Above is the net worth, insider trading, and ownership report for Shreeram Agharkar. You might contact Shreeram Agharkar via mailing address: P.o Box 2042, Princeton Nj 08543.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
